Visalytics
Visalytics
approved EB-2 (NIW)

Scientist

Drug Delivery · China · 2025-07-07

Processing Time
37 days
Decision Date
2025-07-07
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop efficient, biocompatible lipid nanoparticles (LNPs) to serve as vehicles for delivering gene-based therapeutics and anticancer drugs. Her work focuses on optimizing mRNA-based vaccines, co-delivered chemotherapies, and non-invasive anesthetics to enhance targeting and minimize toxicity. She intends to continue leading LNP development for oral and ocular drug delivery systems within the pharmaceutical industry.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor holds substantial merit in gene-based therapies and is of national importance to public health and rare disease management.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to her extensive publication record, citation impact, and history of NIH-supported research.

3 On Balance, Beneficial to Waive Job Offer Met

The petitioner’s unique contributions to drug delivery and vaccine technology make it beneficial for the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on a record of six peer-reviewed journal articles, one book chapter, and 99 citations, with two articles ranked in the top 10–20% of the field. Evidence included the AAPS High Impact Article Award and documentation of 15 peer-review assignments for prestigious journals. The case successfully satisfied all three Dhanasar prongs by demonstrating the national significance of her NIH-supported research.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Awards
Reference Letters Independent
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Nanotechnology · Jordan

WeGreened EB-2 (NIW) approved
Maryland 90 days 2023-05-13
The petitioner proposes to improve the delivery of mRNA therapeutics to increase the effectiveness of gene therapies for incurable conditions. His work focuses on formulating and characterizing novel nanoparticles and developing advanced animal models to test therapeutics for brain diseases like Alzheimer's and anti-cancer drug delivery.
View Case

Assistant Professor

Pharmaceuticals · Syria

WeGreened EB-2 (NIW) approved
65 days 2022-03-23
The petitioner proposes to continue research in the development of new drug delivery carriers based on nanotechnology using a one-step reproducible process. This work focuses on developing DNA and RNA vaccines and treating diseases such as cancer, Alzheimer's, and diabetes. Additionally, the endeavor includes the development of new pediatric drugs designed to mask unpleasant tastes to ease ingestion for children.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
North Carolina 132 days 2024-05-17
The petitioner proposes to continue her research in pharmaceutical sciences, specifically focusing on advancing drug repurposing and the development of nanoparticle-based delivery systems. Her work aims to create smarter, more efficient ways to deliver medications for critical diseases such as cancer and COVID-19. This research is intended to provide faster, cost-effective pathways for translating laboratory discoveries into viable clinical treatments.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 48 days 2025-09-04
The petitioner proposes to develop precision oncology tools by integrating nanotechnology, immunology, and computational methods to engineer next-generation cancer therapies. His work specifically focuses on designing personalized, neoantigen-based nano vaccines and SMART-lipid nanoparticles to improve immune system responsiveness and overcome tumor immune evasion.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 37 days
Criteria Met 3 / 3
Evidence Types 9

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist